The FDA has approved a groundbreaking new drug to slow the progression of Alzheimer's disease in its early stages, offering ...

Kearney physician Dr. Bradley Rodgers will soon offer Kisunla, the first drug proven to slow the early onset of Alzheimer’s.

The Western New York Chapter of the Alzheimer’s Association will offer a free education program on recognizing and understanding Alzheimer’s disease and dementia at 10 a.m. Thursday at ...

Patients will be able to get a 10 minute injection of the Roche drug, instead of an hours-long infusion. Novartis already has ...

The U.S. Food and Drug Administration on Thursday approved Roche's under-the-skin injection to treat patients with multiple ...

Light pollution has been increasing rapidly since the 1970s, posing a threat to the health of humans and wildlife.

Alzheimer disease research is yielding breakthroughs with blood tests and brain scans that can enhance early diagnosis, while ...

LONDON—Britain’s drug regulator authorized the Alzheimer’s drug Leqembi on Thursday, saying it’s the first medicine to show some impact in slowing the progression of the neurodegenerative ...

They used a drug prediction algorithm to predict that ... Their top candidate was DNP, which has been approved since 1996 to treat Alzheimer’s. “Interestingly, clinical overdoses of DNP ...

Aug. 26 (UPI) --The Food and Drug Administration on Monday approved Insulet's Omnipod 5 automated insulin delivery system for people with Type 2 diabetes. In 2022, the FDA signed off on the system ...

After a lull of nearly 2 decades, the Food and Drug Administration ... early-stage Alzheimer’s disease and lower baseline beta-amyloid levels. The FDA has granted lecanemab and donanemab ...

Alzheimer's drug Leqembi for use in the country's national health service (NHS), The Telegraph reported Saturday that their Eli Lilly (NYSE:LLY) will face the same fate for its drug, donanemab.